Maloney DG - Search Results

1

Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD; National Comprehensive Cancer Network. Hoppe RT, et al. Among authors: maloney dg. J Natl Compr Canc Netw. 2008 Jul;6(6):594-622. doi: 10.6004/jnccn.2008.0046. J Natl Compr Canc Netw. 2008. PMID: 18597713 No abstract available.

2

Follicular lymphoma: a model of lymphoid tumor progression in man.

Zelenetz AD, Campbell MJ, Bahler DW, Takahashi S, Oren R, Esserman L, Umetsu DT, Kwak LW, Maloney DG, Brown S, et al. Zelenetz AD, et al. Among authors: maloney dg. Ann Oncol. 1991 Feb;2 Suppl 2:115-22. doi: 10.1007/978-1-4899-7305-4_18. Ann Oncol. 1991. PMID: 2049308 Free article. Review.

3

Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.

Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R. Kaminski MS, et al. Among authors: maloney dg. J Immunol. 1986 Feb 1;136(3):1123-30. J Immunol. 1986. PMID: 3484499

4

Idiotype vaccination against murine B cell lymphoma. Inhibition of tumor immunity by free idiotype protein.

Kaminski MS, Kitamura K, Maloney DG, Levy R. Kaminski MS, et al. Among authors: maloney dg. J Immunol. 1987 Feb 15;138(4):1289-96. J Immunol. 1987. PMID: 3492546

5

Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.

Maloney DG, Kaminski MS, Burowski D, Haimovich J, Levy R. Maloney DG, et al. Hybridoma. 1985 Fall;4(3):191-209. doi: 10.1089/hyb.1985.4.191. Hybridoma. 1985. PMID: 3899906

6

Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody.

Knox S, Hoppe RT, Maloney D, Gibbs I, Fowler S, Marquez C, Cornbleet PJ, Levy R. Knox S, et al. Blood. 1996 Feb 1;87(3):893-9. Blood. 1996. PMID: 8562959 Free article. Clinical Trial.

7

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.

Maloney DG, Grillo-López AJ, White CA, Bodkin D, Schilder RJ, Neidhart JA, Janakiraman N, Foon KA, Liles TM, Dallaire BK, Wey K, Royston I, Davis T, Levy R. Maloney DG, et al. Blood. 1997 Sep 15;90(6):2188-95. Blood. 1997. PMID: 9310469 Free article. Clinical Trial.

8

Non-Hodgkin's lymphoma.

Maloney DG. Maloney DG. Curr Opin Hematol. 1995 Jul;2(4):255-61. doi: 10.1097/00062752-199502040-00004. Curr Opin Hematol. 1995. PMID: 9372005 Review.

9

High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.

Schiffman K, Buckner CD, Maziarz R, Maloney DG, Appelbaum FR, Press O, Gooley T, Holmberg L, Lilleby K, Clift R, Zuckerman N, Klarnet J, Weaver C, Chauncey T, Bensinger WI. Schiffman K, et al. Among authors: maloney dg. Biol Blood Marrow Transplant. 1997 Nov;3(5):261-6. Biol Blood Marrow Transplant. 1997. PMID: 9450921

10

Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone.

Davis TA, Maloney DG, Czerwinski DK, Liles TM, Levy R. Davis TA, et al. Among authors: maloney dg. Blood. 1998 Aug 15;92(4):1184-90. Blood. 1998. PMID: 9694706 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

346 results

Search Page